LBA6 KRYSTAL-1: Adagrasib (MRTX849) as monotherapy or combined with cetuximab (Cetux) in patients (Pts) with colorectal cancer (CRC) harboring a KRASG12C mutation

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 32; p. S1294
Main Authors	Weiss, J., Yaeger, R.D., Johnson, M.L., Spira, A., Klempner, S.J., Barve, M.A., Christensen, J.G., Chi, A., Der-Torossian, H., Velastegui, K., Kheoh, T., Ou, S-H.I.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.09.2021
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1016/j.annonc.2021.08.2093